Publicacións en colaboración con investigadores/as de Hospital Universitario de Salamanca (15)

2020

  1. GEHEP 010 study: Prevalence and distribution of hepatitis B virus genotypes in Spain (2000–2016)

    Journal of Infection, Vol. 81, Núm. 4, pp. 600-606

2016

  1. Perspectiva histórica de la espectrometría de masas en microbiología

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, pp. 3-7

2015

  1. Study of Protein Expresion in Peri-Infarct Tissue after Cerebral Ischemia

    Scientific Reports, Vol. 5

2014

  1. In vivo theranostics at the peri-infarct region in cerebral ischemia

    Theranostics, Vol. 4, Núm. 1, pp. 90-105

  2. Quick adjustment of imaging tracer payload, for in vivo applications of theranostic nanostructures in the brain

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 10, Núm. 4, pp. 851-858

2012

  1. Glutamate Excitoxicity Is the Key Molecular Mechanism Which Is Influenced by Body Temperature during the Acute Phase of Brain Stroke

    PLoS ONE, Vol. 7, Núm. 8

  2. Neuroprotection or increased brain damage mediated by temperature in stroke is time dependent

    PLoS ONE, Vol. 7, Núm. 2

2010

  1. Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain

    Journal of Clinical Microbiology, Vol. 48, Núm. 11, pp. 4200-4206

2009

  1. The Spanish HIV BioBank: A model of cooperative HIV research

    Retrovirology, Vol. 6

2008

  1. Prevalencia de infecciones por Acinetobacter baumannii resistente a carbapenemas en España (1999-2005)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 4, pp. 199-204

  2. Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277

2003

  1. Evolution of penicillin and erythromycin co-resistance in Streptococcus pneumoniae in Spain

    International Journal of Antimicrobial Agents, Vol. 22, Núm. 5, pp. 541-544

2002

  1. Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]

    Journal of Antimicrobial Chemotherapy

1999

  1. Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: Results of a 1-year (1996-1997) multicenter surveillance study

    Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 1, pp. 178-180

1998

  1. Situación epidemiológica actual y resistencia de los patógenos respiratorios en Espan̄a

    Medicina Clinica, Vol. 110, Núm. SUPPL. 1, pp. 44-51